Marriott International is set to make 2026 a landmark year for hospitality across Asia Pacific excluding China, with exciting brand debuts and bold expansions into new destinations. Travelers can look forward toJW Marriott Ranthambore Resort & Spa redefining the great outdoors with a design narrative rooted in the romance of the wild. Fairfield by Marriott […]
Director/PDMR Shareholding GlobeNewswire December 10, 2025 The Magnum Ice Cream Company N.V. (TMICC or the Company) NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS) AND THEIR PERSONS CLOSELY ASSOCIATED (PCA) The Company notifies the following change in interests in the ordinary shares of EUR3.50 each (Shares) of PDMRs, arising pursuant to acquisitions and the
(LSE:MICC),(Euronext Amsterdam:MICC),(NYSE:MICC), The Magnum Ice Cream Company N.V. (TMICC or the Company) NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS) AND THEIR PERSONS CLOSELY ASSOCIATED (PCA) The Company notifies the following change in interests in the ordinary shares of EUR3.50 each (Shares) of PDMRs, arising pursuant to acquisitions and the Admission of TMICC to
The approval marks the first new treatment option for people living with progressive pulmonary fibrosis (PPF) in more than five years. PPF is a rare lung condition, more life-threatening than many forms of cancer, causing a continuous decline in lung function.1,2,3 PPF is the second approved indication in China for nerandomilast, following recent approvals in
JASCAYD(R) (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China GlobeNewswire December 10, 2025 The approval marks the first new treatment option for people living with progressive pulmonary fibrosis (PPF) in more than five years. PPF is a rare lung condition, more life-threatening than many forms of cancer, causing a continuous decline in
According to the latest report published byMordor Intelligence, thecloud managed services marketis poised for steady expansion as enterprises accelerate digital modernization and distributed IT operations, with the market size valued at USD 140.96 billion in 2025 and projected to reach USD 222.81 billion by 2030, reflecting a CAGR of 9.59% during the forecast period. The
Acclaro Medical today announced the launch of its first-ever National 3DMIRACL® Day, a celebration of one of the fastest-growing aesthetic fiber lasertreatments in the U.S. Designed as the ultimate “glow up” refresher, 3DMIRACL® is the go-totreatment for the holiday season and the perfect way to kick off the New Year with smooth,radiant skin. Also launching
The Generation Essentials Group (“TGE” or the “Company”, NYSE and LSE: TGE) refers to its announcement published on December 5, 2025 relating to the approval by the UK Financial Conduct Authority (the “FCA”) of a prospectus for its proposed secondary listing on the London Stock Exchangeplc (the “London Stock Exchange”). The Company hereby announces that
LONDON / COPENHAGEN, Dec. 10, 2025 (GLOBE NEWSWIRE) — United Fintech, the industry-neutral fintech infrastructure and ecosystem for financial institutions, asset managers & wealth managers has secured a strategic investment from Barclays, further strengthening its shareholder base of leading global banks, including BNP Paribas, Citi and Danske Bank and most recently Standard Chartered, which have
Barclays invests in United Fintech, becoming the fifth global bank investor and joins the board GlobeNewswire December 10, 2025 LONDON / COPENHAGEN, Dec. 10, 2025 (GLOBE NEWSWIRE) — United Fintech, the industry-neutral fintech infrastructure and ecosystem for financial institutions, asset managers & wealth managers has secured a strategic investment from Barclays, further strengthening its shareholder